Journal of Urologic Oncology

Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?: Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo; Korean J Urol Oncol. 2022;20(3):139-150. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.139; Full text PubReader ePub PDF

Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: Joongwon Choi, Tae Jin Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Minyong Kang, Seong Il Seo; Korean J Urol Oncol. 2019;17(3):150-159. Published online December 27, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.3.150; Full text PubReader ePub PDF Supplementary Material

How Should We Select Patients for Targeted Therapy?: Cheol Kwak; Korean J Urol Oncol. 2008;6(1):1-7. Published online April 30, 2008; PDF

7,853	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
6,588	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
6,586	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
5,808	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
5,701	Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses

Cited By 9	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 7	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 7	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By 4	Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Cited By 4	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians

Search